core one labs

This Week in Psychedelics - 2.5.21

ThisWeekinPsychedelics.png

Cannabis

  • Democratic Senate Leaders Announce Steps To Federally Legalize Marijuana In 2021 (Marijuana Moment)

  • Idaho Senate Passes Measure To Block Marijuana Legalization, Even If Voters Approve It On The Ballot (Marijuana Moment)

  • Marijuana Legalization Bills Headed to Virginia Senate and House (Filter)

  • Top Minnesota Lawmakers File Marijuana Legalization Bill For 2021 (Marijuana Moment)

  • New Mexico Senators File Two Marijuana Legalization Bills, With More On The Way (Marijuana Moment)

  • Maryland Marijuana Legalization Bill Sponsored By Senate President And Other Top Lawmakers (Marijuana Moment)

  • Alabama Senate Committee Approves Medical Marijuana Legalization Bill (Marijuana Moment)

  • Sustainability In The Cannabis Industry: Truly Going Green (Forbes)

  • Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients (NORML)

  • The “Secret Handshake”—A Program Gifting Cannabis to Unhoused People (Filter)

  • Adult-Use Marijuana Legalization Not Associated with Any Rise in Substance Abuse Treatment Admissions (NORML)

  • Mississippi’s high court to hear arguments to block medical cannabis (Marijuana Business Daily)

  • Philadelphia: Marijuana Treatment Admissions Drop Eighty Percent (NORML)

LSD

  • Neuroscience study indicates that LSD “frees” brain activity from anatomical constraints (PsyPost)

  • Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD (Psilocybin Alpha)

Magic Mushrooms

  • New Jersey Governor Signs Psilocybin Bill To Immediately Reduce Penalties For Possession (Marijuana Moment)

  • Psychedelic Mushroom Bills Filed In Florida And Connecticut As Movement Expands To Multiple States (Marijuana Moment)

  • Federal Judge Decides Against Prison for Denver Mushroom Dealer (Westword)

  • Psilocybin and Neurogenesis: The Long-Term Effects of Magic Mushrooms on Your Brain (Entheonation)

  • COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy (GlobeNewswire)

MDMA

  • MDMA and psilocybin not approved for medicinal use in Australia (9News)

  • MDMA-Assisted Therapy is Less Effective if You Take Antidepressants (DoubleBlind)

DMT

  • Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule” (Psilocybin Alpha)

  • Why Does DMT Pervade Nature? (Reality Sandwich)

Ayahuasca

5-MeO-DMT

  • Psychedelic Toads Pushed To The Limit, Conservationists Urge Synthetic 5-MeO-DMT Option (Forbes)

Novel Psychoactive Substances

  • Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies (Psilocybin Alpha)

Nitrous Oxide

Ketamine

  • Proposed law could bar SC 1st responders from using ketamine to incapacitate suspects (The Post and Courier)

  • PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine (Psilocybin Alpha)

  • PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

  • Psychedelic Wellness-Focused Company Delic to Acquire Ketamine Infusion Centers LLC (PR Newswire)

  • Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas (BioSpace)

Miscellaneous

  • Drug Decriminalization Goes Into Effect in Oregon (Rolling Stone)

  • Cambridge City Council Decriminalizes Psychedelics And Urges Police To End Drug Arrests More Broadly (Marijuana Moment)

  • Washington Lawmakers Introduce Long-Awaited Bill To Decriminalize All Drugs And Expand Treatment (Marijuana Moment)

  • Mass General Launches New Center to Study Psychedelics in Psychiatry (Massachusetts General Hospital)

  • Psychedelics as Antidepressants (Scientific American)

  • Health Canada considers amending Special Access Program (Psillow)

  • QAnon shaman turns against Trump, says he would testify that president incited Capitol riots (National Post)

  • Biden Quietly Announces Harm Reduction Among His Drug Priorities (Filter)

  • Timothy Leary’s Castalia Foundation Has Been Co-opted to Promote Conspiracy Theories about COVID and Elite Pedophile Rings (Psymposia)

  • Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board (Psilocybin Alpha)

  • Neuroscience students launch Psychedelic Society (The Glasgow Guardian)

  • Pharmacological Testing in Psychedelic Research (Psychedelic Science Review)

  • How To Setup Music for Psychedelic Sessions (+ 6 More Playlists for Psilocybin) (Maps of the Mind)

  • Marlene Dobkin de Rios: A Case for Complex Histories of Women in Psychedelics (Chacruna)

  • Is Microdosing Psychedelics the Secret to Sobriety? (MEL Magazine)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.